BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30578545)

  • 1. Evolution in primates by "Catastrophic-selection" interplay between enveloped virus epidemics, mutated genes of enzymes synthesizing carbohydrate antigens, and natural anti-carbohydrate antibodies.
    Galili U
    Am J Phys Anthropol; 2019 Feb; 168(2):352-363. PubMed ID: 30578545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural anti-carbohydrate antibodies contributing to evolutionary survival of primates in viral epidemics?
    Galili U
    Glycobiology; 2016 Nov; 26(11):1140-1150. PubMed ID: 27567275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host Synthesized Carbohydrate Antigens on Viral Glycoproteins as "Achilles' Heel" of Viruses Contributing to Anti-Viral Immune Protection.
    Galili U
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Natural Antibodies to Mammalian Carbohydrate Antigens as Unsung Heroes Protecting against Past, Present, and Future Viral Infections.
    Galili U
    Antibodies (Basel); 2020 Jun; 9(2):. PubMed ID: 32580274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paleo-immunology of human anti-carbohydrate antibodies preventing primate extinctions.
    Galili U
    Immunology; 2023 Jan; 168(1):18-29. PubMed ID: 36161654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
    Galili U
    Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies.
    Galili U
    Front Mol Biosci; 2021; 8():746883. PubMed ID: 34805272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody.
    Galili U
    Springer Semin Immunopathol; 1993; 15(2-3):155-71. PubMed ID: 7504839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of the evolutionary α1,3-galactosyltransferase (GGTA1) gene inactivation in preventing extinction of apes and old world monkeys.
    Galili U
    J Mol Evol; 2015 Jan; 80(1):1-9. PubMed ID: 25315716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody.
    Galili U
    Med Res Arch; 2021 Jul; 9(7):. PubMed ID: 34853815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbohydrate antigen expression and anti-pig antibodies in New World capuchin monkeys: Relevance to studies of xenotransplantation.
    Li Q; Shaikh S; Iwase H; Long C; Lee W; Zhang Z; Wang Y; Ayares D; Cooper DKC; Hara H
    Xenotransplantation; 2019 May; 26(3):e12498. PubMed ID: 30770572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.
    Galili U
    Immunol Cell Biol; 2005 Dec; 83(6):674-86. PubMed ID: 16266320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates.
    Galili U; Clark MR; Shohet SB; Buehler J; Macher BA
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1369-73. PubMed ID: 2434954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reaction.
    Tanemura M; Miyoshi E; Nagano H; Eguchi H; Matsunami K; Taniyama K; Hatanaka N; Akamatsu H; Mori M; Doki Y
    World J Gastroenterol; 2015 Oct; 21(40):11396-410. PubMed ID: 26523105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative and qualitative changes in anti-Neu5Gc antibody response following rabbit anti-thymocyte IgG induction in kidney allograft recipients.
    Rousse J; Salama A; Leviatan Ben-Arye S; Hruba P; Slatinska J; Evanno G; Duvaux O; Blanchard D; Yu H; Chen X; Bach JM; Padler-Karavani V; Viklicky O; Soulillou JP
    Eur J Clin Invest; 2019 Apr; 49(4):e13069. PubMed ID: 30620396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of Neu5Gc and Presence of Anti-Neu5Gc Antibodies in Humans-An Evolutionary Perspective.
    Altman MO; Gagneux P
    Front Immunol; 2019; 10():789. PubMed ID: 31134048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response, accommodation, and tolerance to transplantation carbohydrate antigens.
    Galili U
    Transplantation; 2004 Oct; 78(8):1093-8. PubMed ID: 15502700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-gal A/B, a novel anti-blood group antibody identified in recipients of abo-incompatible kidney allografts.
    Galili U; Ishida H; Tanabe K; Toma H
    Transplantation; 2002 Dec; 74(11):1574-80. PubMed ID: 12490791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual selection by female immunity against paternal antigens can fix loss of function alleles.
    Ghaderi D; Springer SA; Ma F; Cohen M; Secrest P; Taylor RE; Varki A; Gagneux P
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17743-8. PubMed ID: 21987817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.